Xenon Pharmaceuticals Email Formats
Biotechnology Research • 
Burnaby, British Columbia, Canada • 201-500 Employees
Xenon Pharmaceuticals Email Formats
Xenon Pharmaceuticals uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@xenon-pharma.com), used 68.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@xenon-pharma.com | 68.4% |
{first name}.{last name} | john.doe@xenon-pharma.com | 16.1% |
{first initial}.{last name} | j.doe@xenon-pharma.com | 7.8% |
{last name}{last name} | doedoe@xenon-pharma.com | 6.7% |
Key Contacts at Xenon Pharmaceuticals
Will Joseph
Senior Director, Field Based Medicine
Shirley Bachman
Senior Director, Payer Accounts
Manon Bélisle
Senior Director Clinical Development
Ajit Kulkarni
Sr. Director, Medical Affairs Operations
Hemchand K. Sookdeo
Executive Director, Development Program Management
Matthew Lee
Senior Director, Pharmacovigilance And Drug Safety, Risk Management And Safety Governance
Alvin Ong
Director, Value & Access
Jr Sichel
Senior Director Customer Engagement
Daniel Lee
Clinical Development Team Lead Azetukalner - Senior Medical Director
Rohini Chitra
Executive Director
Company overview
| Headquarters | 3650 Gilmore Way, Burnaby, BC V5G 4W8, CA |
| Phone number | +16044843450 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Drug Discovery, Drug Development, Depression, Biopharmaceuticals, MDD, Neurology, Neuroscience, Psychiatry, Neuropsychiatry, Epilepsy, Seizures, FOS, Ion Channels, Sodium Channels, Focal Onset Seizures, Pgtsc, Potassium Channels, Tonic-Clonic Seizures |
| Employees | 201-500 |
| Socials |
About Xenon Pharmaceuticals
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including Kv7 and Nav1.7 programs in Phase 1 development for the potential treatment of pain. We have offices in Vancouver, British Columbia, and Boston, Massachusetts.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Xenon Pharmaceuticals has 201 employees across 17 departments.
Departments
Number of employees
Funding Data
Xenon Pharmaceuticals has never raised funding before.
Xenon Pharmaceuticals Tech Stack
Discover the technologies and tools that power Xenon Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
CDN
PaaS
JavaScript libraries
Tag managers
Operating systems
Reverse proxies
PaaS
Programming languages
Security
Caching
Blogs
Web servers
Frequently asked questions
4.8
40,000 users
